Evidence map›Paper›PMID 16481627›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

Assessment of cystic fibrosis transmembrane conductance regulator (CFTR) activity in CFTR-null mice after bone marrow transplantation.

Emanuela M Bruscia, Joanna E Price, Ee-Chun Cheng, Scott Weiner, Christina Caputo, Elisa C Ferreira, Marie E Egan, Diane S Krause

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 77 citations in OpenAlex.

  1. Trial
  2. Next generation triplex-forming PNAs for site-specific genome editing of the F508del CFTR mutation.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Partial Restoration of CFTR Function in cftr-Null Mice following Targeted Cell Replacement Therapy.Molecular therapy : the journal of the American Society of Gene Therapy · 2017
    Article
  9. Increased susceptibility of Cftr-/- mice to LPS-induced lung remodeling.American journal of physiology. Lung cellular and molecular physiology · 2016
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Advances in cell and gene-based therapies for cystic fibrosis lung disease.Molecular therapy : the journal of the American Society of Gene Therapy · 2012
    Review
  16. Article
  17. Article
  18. Stem cells and cell therapies in lung biology and lung diseases.Proceedings of the American Thoracic Society · 2011
    Article
  19. Article
  20. Optimization of targeted cell replacement therapy: a new approach for lung disease.Molecular therapy : the journal of the American Society of Gene Therapy · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Emanuela M BrusciaDepartment of Laboratory Medicine, Yale University School of Medicine, 330 Cedar Street, New Haven, CT 06520, USA.
Joanna E Price
Ee-Chun Cheng
Scott Weiner
Christina Caputo
Elisa C Ferreira
Marie E Egan
Diane S Krause
Yale University · USPediatrics and Genetics · US

Funding

RESEARCH IN PERINATAL MEDICINET32HD007094 · NICHD · YALE UNIVERSITY · PI GALLAGHER, PATRICK G · 1985 to 2015
$3.6M
Type II pneumocyte engraftment of bone marrow stem cellsR01HL073742 · NHLBI · YALE UNIVERSITY · PI KRAUSE, DIANE S · 2003 to 2012
$3.5M
Epithelial engraftment of bone marrow derived stem cellsR01DK061846 · NIDDK · YALE UNIVERSITY · PI KRAUSE, DIANE S · 2001 to 2008
$2.5M
CFTR REGULATION OF ION CHANNELSR01DK053428 · NIDDK · YALE UNIVERSITY · PI EGAN, MARIE E · 1998 to 2006
$1.4M
NHLBI NIH HHS HL073742NHLBI NIH HHS R01 HL073742NICHD NIH HHS T32 HD007094NICHD NIH HHS T32HD007094NIDDK NIH HHS DK053428NIDDK NIH HHS DK061846NIDDK NIH HHS R01 DK053428NIDDK NIH HHS R01 DK061846
6 · The paper itself

Abstract

Several studies have demonstrated that bone marrow (BM)-derived cells give rise to rare epithelial cells in the gastrointestinal (GI) and respiratory tracts after BM transplantation into myeloablated recipients. We investigate whether, after transplantation of cystic fibrosis transmembrane conductance regulator (CFTR)-positive BM-derived cells, BM-derived GI and airway epithelial cells can provide CFTR activity in the GI tract and nasal epithelium of recipient cystic fibrosis mice. CFTR-/- mice were transplanted with wild-type BM after receiving different doses of irradiation, and CFTR activity was assessed in vivo in individual mice over time by using rectal and nasal potential difference analyses and in vitro by Ussing chamber analysis. The data suggest that rare BM-derived epithelial cells in the GI and nasal epithelium detected in CFTR-/- transplanted mice provide a modest level of CFTR-dependent chloride secretion. Detection of CFTR mRNA and protein in tissues of transplanted CFTR-/- mice supports these data.

Indexed as

Bone Marrow TransplantationGenetic TherapyAnimalsCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorGastric MucosaIntestinal MucosaMiceMice, Inbred CFTRNasal MucosaRNA, MessengerCystic Fibrosis Transmembrane Conductance RegulatorRNA, Messenger

Identifiers

PMID16481627
PMCPMC1413802
OpenAlexW2062037030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.